Sleep
Apnea Device Market: By Type (Therapeutic (CPAP, PAP, Facial Interfaces Mask,
Oral Appliance, Mandibular Advancement Device) and Diagnostic (PSG, Oximeter)),
End-User (Sleep Laboratories, Hospitals, Home Care & Clinics) – Forecast
Till 2022
The
global Sleep Apnea Device Market is expected to reach an approximate CAGR of 7.8% during the
forecast period. Sleep apnea is a serious disorder, wherein breathing is
interrupted for a brief or repeated period of
time during sleep. Apnea means ‘no breath’ and sleep apnea causes a
pause in breathing for at least ten seconds. Sleep
apnea is divided into two types, obstructive and central sleep apnea. The former is caused due to a blockage of the upper
airway. Whereas, the latter occurs when the brain is not able to
properly control breathing during sleep. Untreated sleep apnea causes a person
to experience repeated instances of pause in breathing during their sleep. In
such cases, the brain and the rest of the body are
not able to get enough oxygen intake. Sleep apnea devices are of immense importance
in treating obstructive sleep apnea (OSA), a prevalent medical condition that
affects a large number of people worldwide. The latest report revealed by
Market Research Future (MRFR) reveals that the global sleep apnea devices
market to attain an anticipated CAGR figure of 7.8% during the forecast period.
The
market is increasing at a rapid pace due to the increasing number of
individuals being affected by OSA and the
advancing technologies in the healthcare sector. Additionally, increasing
problems related to obesity and an increasing
old-age population is causing more and more patients to be affected with sleep
apnea, thereby further pushing the demand for these devices. Another factor
that is influencing a positive demand in the market is the increasing
preference of patients for such devices instead of opting for surgical
treatments for these sleep disorders.
Amidst
all the positive signs, the high cost of the devices and the availability of
various other alternative treatment methods can restrain the market growth of
these devices.
Market
Segmentation
The
global sleep apnea device market segmentation
is classified on the following basis: types and end-user.
By
type, the market segments into diagnostic and therapeutic sleep apnea devices.
The therapeutic segment narrows down into Positive Airway
Pressure (PAP) devices, Adaptive Servo-Ventilators (ASV), Continuous Positive
Airway Pressure (CPAP), oral appliances, facial interfaces (mask), accessories,
and other therapeutic devices such as airway clearance systems and oxygen
concentrators.
The diagnostic segment divides into oximeter and Polysomnographs (PSG).
By
end-user, the market includes home care, hospitals, and sleep laboratories.
During the forecast period, the home care segment is expected to grow at a
massive scale.
Browse
Complete Report :https://www.marketresearchfuture.com/reports/sleep-apnea-devices-market-2061
Regional Analysis
The
geographical segmentation of the global Sleep Apnea Devices market comprises of
four major regions – North America, Asia-Pacific, Europe, and the Rest of the
World.
North
America is the biggest market holder in
the global sleep apnea devices market. Factors supporting the growth of the
market are the wide-spread prevalence of
sleep apnea, the proliferating demand for these devices, and increasing
investments from private as well as government institutions to promote
awareness concerning the same. Europe is the second-largest market for these
devices due to the use of non-invasive and painless cardiorespiratory monitors.
Asia-Pacific
is positioned to register the highest growth percentage during the assessment
period. Herein, the key factors driving the market are the rising prevalence of
sleep disorders, the undiagnosed pool of
patients in countries like India, and a growing impetus on raising the
awareness of sleep apnea by government
and private institutions. Lastly, the Middle East & Africa boasts the least
market share owing to the presence of strict government policies and poor
economic condition.
Competitive
Analysis
The
global Sleep Apnea Devices market hosts a pool of noteworthy players, including
BMC Medical Co, Ltd (China), Fisher & Paykel Healthcare Limited (New
Zealand), Koninklijke Philips N.V. (Netherlands), Curative Medical (U.S.), Invacare
Corporation (U.S.), GE Healthcare (U.S.), ResMed (U.S), Cadwell Industries, Inc
(U.S.), Braebon Medical Corporation (Canada), and ImThera Medical Inc. (U.S.).
On Feb 15th,
2019, an announcement was made concerning the agreement between Impression
Healthcare Ltd. and RespireRx Pharmaceuticals Inc. The move aims to
commercialize dronabinol, a form of cannabinoid, for the treatment of
Obstructive Sleep Apnea (OSA) in Southeast Asia and Australia and New Zealand.
No comments:
Post a Comment